- $10.91bn
- $13.30bn
- $4.09bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 12.25 | ||
| PEG Ratio (f) | 2.16 | ||
| EPS Growth (f) | 6.03% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.31 | ||
| Price to Tang. Book | 3.63 | ||
| Price to Free Cashflow | 16.1 | ||
| Price to Sales | 2.58 | ||
| EV to EBITDA | 14.33 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 5.04% | ||
| Return on Equity | 6.84% | ||
| Operating Margin | 12.84% | ||
Financial Summary
| Year End 31st Oct | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 2,922.5 | 3,308.4 | 3,593.2 | 3,895.4 | 4,092.4 | 4,239.09 | 4,409.4 | 10.98% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +1022.42 | -85.99 | -21.11 | +19.52 | -4.24 | +141.61 | +3.62 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
The Cooper Companies, Inc. is a medical device company. The Company's segments include CooperVision and CooperSurgical. The CooperVision segment is engaged in developing, manufacturing and marketing a broad range of products for contact lens wearers, featuring advanced materials and optics. Its daily disposable silicone hydrogel contact lens products include MyDay daily disposable, MyDay daily disposable toric, MyDay daily disposable multifocal, and MyDay Energys. The CooperSurgical segment provides a portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. Its brands include ALLY II UPS, Advincula Delineator, Apple-Hunt Secondary Cannula, Bakri Postpartum Balloon, California Cryobank, Carter-Thomason, Cell Care, Cells for Life, Coda, Cord Blood Registry, Core Cryolab, Donor Egg Bank USA, ER-Complete, Embryo Options, and Endosee.
Directors
- Robert Weiss NEC (75)
- Albert White PRE (52)
- Brian Andrews CFO (43)
- Holly Sheffield CEX (51)
- Gerard Warner CEX (57)
- Daniel McBride COO (57)
- Agostino Ricupati SVF (55)
- Mark Drury VPR (46)
- William Kozy LED (70)
- Colleen Jay IND (59)
- Jody Lindell IND (70)
- Teresa Madden IND (65)
- Gary Petersmeyer IND (74)
- Maria Rivas IND (58)
- Last Annual
- October 31st, 2025
- Last Interim
- July 31st, 2026
- Incorporated
- March 4th, 1980
- Public Since
- January 21st, 1983
- No. of Shareholders
- 141
- No. of Employees
- 15,000
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
NASDAQ Global Select Market- Shares in Issue
- 190,155,294
- Address
- 6101 Bollinger Canyon Road, Suite 500, SAN RAMON, 94583
- Web
- https://www.coopercos.com/
- Phone
- +1 3026365400
- Contact
- Kim Duncan
- Auditors
- KPMG LLP
Latest News for COO
Upcoming Events for COO
Q4 2026 Cooper Companies Inc Earnings Release
Q1 2027 Cooper Companies Inc Earnings Release
Cooper Companies Inc Annual Shareholders Meeting
Similar to COO
10x Genomics
NASDAQ Global Select Market
Alamar Biosciences
NASDAQ Global Select Market
Align Technology
NASDAQ Global Select Market
Alphatec Holdings
NASDAQ Global Select Market
AngioDynamics
NASDAQ Global Select Market
FAQ
As of Today at 02:04 UTC, shares in The Cooper Companies are trading at $57.40. This share price information is delayed by 15 minutes.
Shares in The Cooper Companies last closed at $57.40 and the price had moved by -16.52% over the past 365 days. In terms of relative price strength the The Cooper Companies share price has underperformed the S&P500 Index by -28.54% over the past year.
The overall consensus recommendation for The Cooper Companies is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Cooper Companies does not currently pay a dividend.
The Cooper Companies does not currently pay a dividend.
The Cooper Companies does not currently pay a dividend.
To buy shares in The Cooper Companies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $57.40, shares in The Cooper Companies had a market capitalisation of $10.91bn.
Here are the trading details for The Cooper Companies:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: COO
Based on an overall assessment of its quality, value and momentum The Cooper Companies is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in The Cooper Companies is $69.07. That is 20.33% above the last closing price of $57.40.
Analysts covering The Cooper Companies currently have a consensus Earnings Per Share (EPS) forecast of $4.53 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like The Cooper Companies. Over the past six months, its share price has underperformed the S&P500 Index by -24.79%.
As of the last closing price of $57.40, shares in The Cooper Companies were trading -18.19% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The The Cooper Companies PE ratio based on its reported earnings over the past 12 months is 12.25. The shares last closed at $57.40.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
The Cooper Companies' management team is headed by:
- Robert Weiss - NEC
- Albert White - PRE
- Brian Andrews - CFO
- Holly Sheffield - CEX
- Gerard Warner - CEX
- Daniel McBride - COO
- Agostino Ricupati - SVF
- Mark Drury - VPR
- William Kozy - LED
- Colleen Jay - IND
- Jody Lindell - IND
- Teresa Madden - IND
- Gary Petersmeyer - IND
- Maria Rivas - IND